Prasol Chemicals IPO Day 3: Subscribed 1.26x; QIB leads at 1.48x
- Prasol Chemicals IPO closes with 1.26x total subscription on Day 3.
- QIB category leads demand with 1.48x subscription.
- Retail investors subscribed 1.32x; NII (bHNI) at 1.50x.
- Issue price band is ₹643 - ₹676 with min bid qty of 22 shares.

*this image is generated using AI for illustrative purposes only.
Prasol Chemicals IPO closed on Day 3 with a total subscription of 1.26 times. Qualified Institutional Buyers (QIB) drove the strongest demand at 1.48x, while Retail investors subscribed 1.32x. The issue opened on September 8, 2026, and closed on September 10, 2026.
Subscription Status
The IPO saw steady accumulation of bids over the three-day window. Demand accelerated significantly on the final day, pushing the overall subscription above the break-even mark. NII (bHNI) and Retail categories showed notable intraday momentum in the final hours.
| Day | Date | QIB | NII (bHNI) | NII (sHNI) | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 | 08-09-2026 | 0.00x | 0.60x | 0.16x | 0.68x | 0.41x |
| Day 2 | 09-09-2026 | 0.05x | 1.22x | 0.37x | 1.12x | 0.72x |
| Day 3 | 10-09-2026 | 1.48x | 1.50x | 0.50x | 1.32x | 1.26x |
Category-wise Breakdown
Qualified Institutional Buyers (QIB) emerged as the leading category, subscribing 1.48 times. Non-Institutional Investors (NII) in the big HNI (bHNI) segment also showed strong interest at 1.50x. Retail participation stood at 1.32x, while the small HNI (sHNI) segment subscribed 0.50x. Employee quota remained unsubscribed at 0x.
Intra-day Timeline
Subscription figures were updated on the final day, reflecting the closing totals across categories. NII (bHNI) jumped +5.6% today (from 1.42x to 1.50x), while Retail jumped +4.8% today (from 1.26x to 1.32x).
| Time (IST) | QIB | NII (bHNI) | Retail | Total |
|---|---|---|---|---|
| 11:15 | 1.48x | 1.42x | 1.26x | 1.22x |
| 12:15 | 1.48x | 1.50x | 1.32x | 1.26x |
Offer Details
- Price Band: ₹643 - ₹676
- Issue Size: ₹14,146 - ₹500,000
- Min Bid Qty: 22 shares
- Open Date: 2026-09-08
- Close Date: 2026-09-10
About the Company
Prasol Chemicals Limited is a forward integrated manufacturer of acetone and phosphorous based specialty chemicals with over 33 years of experience. The company operates two manufacturing facilities in Maharashtra with an aggregate installed capacity of 98,644 metric tonnes per annum. It produces over 150 specialty chemical products across five key segments: performance chemicals, PICA (paints, inks, construction & adhesives), pharmaceuticals, agrochemicals, and home and personal care. Prasol serves over 1,600 customers globally and exports to 69 countries.
Financial Highlights
Revenue from operations grew from ₹876.57 million in Fiscal 2024 to ₹1,232.59 million in Fiscal 2026. Profit before tax increased from ₹33.51 million in Fiscal 2024 to ₹111.90 million in Fiscal 2026.
| Metric | Fiscal 2024 | Fiscal 2025 | Fiscal 2026 |
|---|---|---|---|
| Revenue from Operations (₹ million) | 876.57 | 1,012.49 | 1,232.59 |
| Profit Before Tax (₹ million) | 33.51 | 59.29 | 111.90 |
| Total Profit (₹ million) | 18.13 | 43.57 | 83.12 |
Objects of the Issue
- Repayment and/or pre-payment of certain borrowings: ₹60.00 crore
- General corporate purposes
Risk Factors
- Manufacturing Facility Dependency: The company relies on two facilities in Maharashtra, which have faced regulatory shutdowns by MPCB in the past.
- Hazardous Materials: Handling of hazardous raw materials poses safety risks, with past incidents including gas leakage and chemical exposure.
- Litigation: The company faces various legal proceedings, including statutory, criminal, and tax proceedings.
- Cash Flow Volatility: Net cash from operating activities has fluctuated significantly between fiscal years.
- Contingent Liabilities: Aggregate contingent liabilities were ₹1,091.22 million as of March 31, 2026.
How might the significant regulatory shutdown history and contingent liabilities impact Prasol Chemicals' post-IPO valuation and investor confidence?
Given the heavy allocation to debt repayment, what is the projected timeline for Prasol Chemicals to achieve debt-free status and improve operating cash flow stability?
Will the strong QIB and bHNI demand translate into a substantial listing gain, or will the modest overall subscription signal cautious market sentiment for specialty chemical IPOs?


























